Creo Medical Share Discussion Threads

[dr biotech] 13/12/2024 10:14

Looks like quite a few of those trials have progressed. Hope some will report within the next few months.

I don’t see any particular reason for the small recovery, just oversold. Would be happy to be proved wrong.

[peterrr3] 13/12/2024 10:03

Given the directors didn't buy yesterday maybe you are right there Foetus. I'm definitely not complaining about the newfound popularity.

[foetus in your brain] 13/12/2024 09:45

Definitely looks like something is up here.

[peterrr3] 12/12/2024 20:02

Credit where credit is due, they have actually started one of the numerous clinical trials they have registered over the years. Better late than never.Reporting in a year. I don't know where you are getting this imminent news from, certainly not the trial program.https://clinicaltrials.gov/study/NCT06476678?term=Creo%20medical&rank=3

[protrader3] 12/12/2024 18:35

You'll be opening that drawer sooner than you think!

[nimbo10] 12/12/2024 17:09

Joys of investing in AIM, why would anyone bother. Have put in bottom drawer, either kaput or decent recovery. Will be patient for couple of years, just seen capitulation today.

[protrader3] 12/12/2024 14:33

That was likely the bottom. Beautiful daily candle forming.

[dr biotech] 12/12/2024 14:15

Perhaps the continual seller has finally finished. Slide has been long and deep so never really sure.

[protrader3] 12/12/2024 13:33

Took another 221k on that tree shake earlier. Happy with that.

[lawson27] 12/12/2024 13:11

Looks like it was a smash and grab by the MM's this morn, before a rise, how many times do we see that, tut tut!

[kemche] 12/12/2024 10:27

£51m mkt cap says a lot of hope is still baked in.

[peterrr3] 12/12/2024 10:24

It went down on low volume, nothing more rotten than the usual in Wales, to bring the Bard up to date. I didn't expect to break even on this before China closing, so maybe an early Xmas present for me if it can scramble another half p higher.

[kemche] 12/12/2024 10:10

Something is rotten in the state of Denmark according to the price action.

[peterrr3] 12/12/2024 09:13

Yes Dr B. I have been averaging down as I think a good takeover target with the consumables business alone now.

[dr biotech] 12/12/2024 08:58

Intuitive and CMR have both chosen to work with them which is the only glimmer of hope. Valuation here is now less than cash and the consumables business. Priced for value destruction, which to be fair is all we have so far seen.

[peterrr3] 12/12/2024 06:00

I would love to be convinced otherwise protrader, so please explain your reasoning as you haven't. Not my down thumb btw. How are their products going to get accepted quickly with no trials started, a 2 year turnaround and 300k of sales in the US last year when they have been there for years?Not one professional body has recommended them. I haven't seen an article where someone not on the payroll as a trainer has said they love using. There may be a logical answer I have missed.

[protrader3] 11/12/2024 22:07

Things will change very quickly here. I am very confident in my substantial investment. This is a great opportunity to add. Research is key. I have thoroughly researched the company and team leading it. More than happy to hold and reap the rewards.

[peterrr3] 10/12/2024 20:08

Not true protrader, I like the tech and hold but management have been very loose with the truth as to rollout, whilst overpaying themselves, with obvious poor oversight by supposedly independent board members. The management team is also rated low by their employees, so I am hoping they will be taken over by someone who knows how to run a business. They have trials first documented in 2018 which haven't started yet, in fact nothing has started and there is no accountability for that fact.

[protrader3] 09/12/2024 18:18

You obviously aren't invested here then with such a negative view.

[peterrr3] 09/12/2024 16:52

Have a look at the clinical trials database and show me the progress. The answer is depressing.

[peterrr3] 09/12/2024 16:50

If the team had a more equity weighted package rather than nose in the trough before selling anything I would have more comfort there was medium term value before burning through the cash. You do know there will be no trial data or NICE before 2026 now?

[protrader3] 07/12/2024 17:44

I think you need to research the team leading this company a little more. Their track recird is superb. Patience will be massively rewarded here. The share price is not reflecting what this company can and will achieve. AIM is about potential. This is the time to load up. As always DYOR.

[peterrr3] 07/12/2024 16:54

These were the sort of EU holdup problems I was thinking ofhttps://www.whitecase.com/insight-alert/new-european-trade-tool-first-investigation-under-international-procurement

[peterrr3] 07/12/2024 16:35

BM I expect the deal to close eventually and do well on this share irrespective on the news, especially if it retreats further in price. And someone is obviously beavering away in the background organising and registering trials, although everything is 2 years plus away from completing and gets moved right a year every year. I would like to know the reason why, when the local trial leads are prolifically pumping out completion reports on similar every few weeks. These are the thought leaders and trainers who are paid but obviously don't prioritise Creo's products in theatre.